Showing all published months. Partner preview tables include up to 20 countries.
USD value by month, all available partner countries combined
Free partner preview shows up to 20 countries.
Total value across the selected data period
| Partner | Value | Share |
|---|---|---|
| Hong Kong | $608M | 47.6% |
| Malaysia | $119.3M | 9.3% |
| United States | $72.4M | 5.7% |
| Japan | $58.1M | 4.6% |
| Indonesia | $42M | 3.3% |
| Singapore | $37.6M | 2.9% |
| Macao | $37.5M | 2.9% |
| Australia | $24M | 1.9% |
| Canada | $22.3M | 1.8% |
| Vietnam | $21.9M | 1.7% |
| Myanmar | $18.7M | 1.5% |
| Laos | $16.7M | 1.3% |
| Netherlands | $13M | 1.0% |
| Thailand | $12.9M | 1.0% |
| South Korea | $12.3M | 1.0% |
| Russia | $12.2M | 1.0% |
| Philippines | $11.9M | 0.9% |
| Nigeria | $9.7M | 0.8% |
| Kazakhstan | $8.1M | 0.6% |
| Germany | $7.6M | 0.6% |
Availability is confirmed when the API response loads.
| Partner | Value | Share |
|---|---|---|
| Hong Kong | $4.8M | 42.9% |
| Macao | $1.4M | 12.7% |
| United States | $969.9K | 8.6% |
| Indonesia | $576.4K | 5.1% |
| Singapore | $571.2K | 5.1% |
| Japan | $255.2K | 2.3% |
| Uzbekistan | $246.6K | 2.2% |
| Myanmar | $223.9K | 2.0% |
| Malaysia | $217.3K | 1.9% |
| Vietnam | $206.9K | 1.8% |
| Ghana | $184.8K | 1.6% |
| Australia | $179K | 1.6% |
| Netherlands | $176.4K | 1.6% |
| Nigeria | $155.4K | 1.4% |
| Russia | $142.5K | 1.3% |
| Philippines | $134K | 1.2% |
| North Korea | $93.7K | 0.8% |
| Mozambique | $86.4K | 0.8% |
| United Kingdom | $78.1K | 0.7% |
| New Zealand | $74.2K | 0.7% |
| Year | Export value |
|---|---|
| 2021 | $207M |
| 2022 | $280M |
| 2023 | $240M |
| 2024 | $247M |
| 2025 | $202.7M |
| 2026 | $99.6M |
Public data shows up to 20 partner countries for this exact eight-digit customs code. Request all available partner-month rows in CSV or Excel.
HS 30049059 is also written 3004.90.59. Values are in USD; the public series does not report tonnes or kg. Product scope: Traditional Chinese medicinal preparations for retail sale or measured dosing, excluding the specifically classified Angong niuhuang wan formulation. The public page shows monthly export partner previews from official GACC customs statistics. Full partner-month rows are available through a scoped custom data request.
Source: China General Administration of Customs (GACC), cleaned and structured by China Data Portal.
Transformations: Values are presented as published by the source.
China Data Portal. "China Other medicaments of Chinese type, nes, in measured doses or in retail packings (HS 30049059) Export Data." https://chinadata.live/china-trade/hs8/30049059/
HS 30049059 is also written 3004.90.59. Values are in USD; the public series does not report tonnes or kg. Product scope: Traditional Chinese medicinal preparations for retail sale or measured dosing, excluding the specifically classified Angong niuhuang wan formulation. The public page shows monthly export partner previews from official GACC customs statistics. Full partner-month rows are available through a scoped custom data request.
Source: China General Administration of Customs (GACC), cleaned and structured by China Data Portal.
Transformations: Values are presented as published by the source.
China Data Portal. "China Other medicaments of Chinese type, nes, in measured doses or in retail packings (HS 30049059) Export Data." https://chinadata.live/china-trade/hs8/30049059/
China exported $184M of other medicaments of chinese type, nes, in measured doses or in retail packings in the twelve months to July 2026, averaging $15.3M per month, based on official China customs statistics (HS 30049059).
Traditional Chinese medicinal preparations for retail sale or measured dosing, excluding the specifically classified Angong niuhuang wan formulation.
Hong Kong, Malaysia and United States together account for 63% of the published total, out of 87 trading partners on record.
Annual exports declined by 2% between 2021 and 2025, from $207M to $203M.
Figures come from official China General Administration of Customs (GACC) statistics, published monthly. ChinaData cleans partner names, periods and values so the series is ready for analysis. Partner-level rows for every month, including HS8 detail, are available on request.